ACR 64: Alzheimer’s Disease and Brain Awareness Month and The Longest Day.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2023-07-17
Current Status:
Passed
(2023-07-17: Chaptered by Secretary of State - Res. Chapter 119, Statutes of 2023.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
This measure would declare the month of June 2023 as Alzheimers Disease and Brain Awareness Month, recognize Wednesday, June 21, 2023, as The Longest Day, and would urge all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month.
This measure would declare the month of June 2023 as Alzheimers Disease and Brain Awareness Month, recognize Wednesday, June 21, 2023, as The Longest Day, and would urge all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month.
This measure would declare the month of June 2023 as Alzheimers Disease and Brain Awareness Month, recognize Wednesday, June 21, 2023, as The Longest Day, and would urge all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month.
WHEREAS, The month of June 2023 has been declared Alzheimers Disease and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs; and
WHEREAS, The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimers disease with a day of activity and advocacy; and
WHEREAS, Alzheimers disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment; and
WHEREAS, California has 690,000 residents living with Alzheimers disease, more than any other state in the nation; and
WHEREAS, Recent research published by the State Department of Public Health in 2021 indicates that over the next 20 years, the impact of Alzheimers disease and related dementia will increase dramatically. While the population of California will expand by 16 percent, the population of people living with Alzheimers disease will expand by 127 percent; and
WHEREAS, Research on the expansion of people living with Alzheimers disease showed communities of color will shoulder a disproportionate share of the increase in prevalence of Alzheimers disease. The number of Latinx or Hispanic Californians living with Alzheimers disease will more than triple, while the number of Black Californians living with Alzheimers disease will nearly triple, by 2040. Additionally, the number of Asian Americans and Pacific Islanders living with Alzheimers disease will more than double; and
WHEREAS, Californians with dementia visit emergency departments nearly 1,000,000 times per year and are readmitted to the hospital one out of five times after discharge; and
WHEREAS, Alzheimers disease is always fatal, and it is the third leading cause of death in California today; and
WHEREAS, Alzheimers disease is a family disease, impacting 1,120,000 California spouses, partners, children, siblings, grandchildren, and other relatives who provide unpaid assistance to a loved one; and
WHEREAS, California caregivers devote 884,000,000 hours of unpaid assistance to family members, valued at over $18,126,000,000 in nongovernmental financial support; and
WHEREAS, Californias 2015 Behavioral Risk Factor Surveillance System survey found that 27.1 percent of people with memory problems in California live alone; and
WHEREAS, Disparities in detection and diagnosis persist, resulting in less than 50 percent of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record; and
WHEREAS, On average, a person with Alzheimers disease lives 4 to 8 years after diagnosis, but may live as long as 20 years, depending on other factors; and
WHEREAS, Age is the greatest risk factor for Alzheimers disease, which has no known cause, cure, or prevention; and
WHEREAS, Californians invest in Alzheimers disease research through the voluntary contribution funds and have raised more than $25,000,000 since its inception for research into treatments to slow the progression of, and develop a cure for, the disease; and
WHEREAS, Individuals living with Alzheimers disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimers disease and related dementias; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares June 2023 as Alzheimers Disease and Brain Awareness Month, recognizes Wednesday, June 21, 2023, as The Longest Day, and urges all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, The month of June 2023 has been declared Alzheimers Disease and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs; and
WHEREAS, The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimers disease with a day of activity and advocacy; and
WHEREAS, Alzheimers disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment; and
WHEREAS, California has 690,000 residents living with Alzheimers disease, more than any other state in the nation; and
WHEREAS, Recent research published by the State Department of Public Health in 2021 indicates that over the next 20 years, the impact of Alzheimers disease and related dementia will increase dramatically. While the population of California will expand by 16 percent, the population of people living with Alzheimers disease will expand by 127 percent; and
WHEREAS, Research on the expansion of people living with Alzheimers disease showed communities of color will shoulder a disproportionate share of the increase in prevalence of Alzheimers disease. The number of Latinx or Hispanic Californians living with Alzheimers disease will more than triple, while the number of Black Californians living with Alzheimers disease will nearly triple, by 2040. Additionally, the number of Asian Americans and Pacific Islanders living with Alzheimers disease will more than double; and
WHEREAS, Californians with dementia visit emergency departments nearly 1,000,000 times per year and are readmitted to the hospital one out of five times after discharge; and
WHEREAS, Alzheimers disease is always fatal, and it is the third leading cause of death in California today; and
WHEREAS, Alzheimers disease is a family disease, impacting 1,120,000 California spouses, partners, children, siblings, grandchildren, and other relatives who provide unpaid assistance to a loved one; and
WHEREAS, California caregivers devote 884,000,000 hours of unpaid assistance to family members, valued at over $18,126,000,000 in nongovernmental financial support; and
WHEREAS, Californias 2015 Behavioral Risk Factor Surveillance System survey found that 27.1 percent of people with memory problems in California live alone; and
WHEREAS, Disparities in detection and diagnosis persist, resulting in less than 50 percent of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record; and
WHEREAS, On average, a person with Alzheimers disease lives 4 to 8 years after diagnosis, but may live as long as 20 years, depending on other factors; and
WHEREAS, Age is the greatest risk factor for Alzheimers disease, which has no known cause, cure, or prevention; and
WHEREAS, Californians invest in Alzheimers disease research through the voluntary contribution funds and have raised more than $25,000,000 since its inception for research into treatments to slow the progression of, and develop a cure for, the disease; and
WHEREAS, Individuals living with Alzheimers disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimers disease and related dementias; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares June 2023 as Alzheimers Disease and Brain Awareness Month, recognizes Wednesday, June 21, 2023, as The Longest Day, and urges all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, The month of June 2023 has been declared Alzheimers Disease and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs; and
WHEREAS, The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimers disease with a day of activity and advocacy; and
WHEREAS, Alzheimers disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment; and
WHEREAS, California has 690,000 residents living with Alzheimers disease, more than any other state in the nation; and
WHEREAS, Recent research published by the State Department of Public Health in 2021 indicates that over the next 20 years, the impact of Alzheimers disease and related dementia will increase dramatically. While the population of California will expand by 16 percent, the population of people living with Alzheimers disease will expand by 127 percent; and
WHEREAS, Research on the expansion of people living with Alzheimers disease showed communities of color will shoulder a disproportionate share of the increase in prevalence of Alzheimers disease. The number of Latinx or Hispanic Californians living with Alzheimers disease will more than triple, while the number of Black Californians living with Alzheimers disease will nearly triple, by 2040. Additionally, the number of Asian Americans and Pacific Islanders living with Alzheimers disease will more than double; and
WHEREAS, Californians with dementia visit emergency departments nearly 1,000,000 times per year and are readmitted to the hospital one out of five times after discharge; and
WHEREAS, Alzheimers disease is always fatal, and it is the third leading cause of death in California today; and
WHEREAS, Alzheimers disease is a family disease, impacting 1,120,000 California spouses, partners, children, siblings, grandchildren, and other relatives who provide unpaid assistance to a loved one; and
WHEREAS, California caregivers devote 884,000,000 hours of unpaid assistance to family members, valued at over $18,126,000,000 in nongovernmental financial support; and
WHEREAS, Californias 2015 Behavioral Risk Factor Surveillance System survey found that 27.1 percent of people with memory problems in California live alone; and
WHEREAS, Disparities in detection and diagnosis persist, resulting in less than 50 percent of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record; and
WHEREAS, On average, a person with Alzheimers disease lives 4 to 8 years after diagnosis, but may live as long as 20 years, depending on other factors; and
WHEREAS, Age is the greatest risk factor for Alzheimers disease, which has no known cause, cure, or prevention; and
WHEREAS, Californians invest in Alzheimers disease research through the voluntary contribution funds and have raised more than $25,000,000 since its inception for research into treatments to slow the progression of, and develop a cure for, the disease; and
WHEREAS, Individuals living with Alzheimers disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimers disease and related dementias; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares June 2023 as Alzheimers Disease and Brain Awareness Month, recognizes Wednesday, June 21, 2023, as The Longest Day, and urges all Californians to commemorate the month of June 2023 as Alzheimers Disease and Brain Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Jul 17, 2023 | Chaptered by Secretary of State - Res. Chapter 119, Statutes of 2023. |
| Jul 17, 2023 | Enrolled and filed with the Secretary of State at 2 p.m. |
| Jul 6, 2023 | In Assembly. Ordered to Engrossing and Enrolling. |
| Jul 6, 2023 | Adopted and to Assembly. (Ayes 40. Noes 0. Page 1917.) |
| Jul 5, 2023 | Ordered to special consent calendar. |
| Jun 28, 2023 | From committee: Ordered to third reading. |
| Jun 20, 2023 | In Senate. To Com. on RLS. |
| Jun 19, 2023 | Adopted and to Senate. (Page 2287.) |
| Jun 19, 2023 | Coauthors revised. |
| Jun 15, 2023 | From committee: Be adopted. Ordered to Third Reading. (Ayes 13. Noes 0.) (June 15). |
| Apr 27, 2023 | Referred to Com. on RLS. |
| Apr 21, 2023 | From printer. |
| Apr 20, 2023 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jul 6, 2023 | Special Consent ACR64 Bains et al. | Senate Floor |
Passed |
|
| Jun 15, 2023 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 64 |
THIRD READING
Bill No: ACR 64
Author: Bains (D), et al.
Introduced: 4/20/23
Vote: 21
ASSEMBLY FLOOR: Read and adopted, 6/19/23
SUBJECT: Alzheimer’s Disease and Brain Awareness Month and The Longest Day
SOURCE: Author
DIGEST:
This resolution declares the month of June 2023 as Alzheimer’s Disease and Brain Awareness Month, recognizes Wednesday, June 21, 2023, as The Longest Day, and urges all Californians to commemorate the month of June 2023 as Alzheimer’s Disease and Brain Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- The month of June 2023 has been declared Alzheimer’s Disease and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs.
- The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimer’s disease with a day of activity and advocacy.
- Alzheimer’s disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment.
- Alzheimer’s disease is always fatal, and it is the third leading cause of death in California today.
- Disparities in detection and diagnosis persist, resulting in less than 50 percent of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record.
- On average, a person with Alzheimer’s disease lives 4 to 8 years after diagnosis, but may live as long as 20 years, depending on other factors.
- Age is the greatest risk factor for Alzheimer’s disease, which has no known cause, cure, or prevention.
- Individuals living with Alzheimer’s disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimer’s disease and related dementias.
This resolution declares June 2023 as Alzheimer’s Disease and Brain Awareness Month, recognizes Wednesday, June 21, 2023, as The Longest Day, and urges all Californians to commemorate the month of June 2023 as Alzheimer’s Disease and Brain Awareness Month.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 6/26/23)
None received
OPPOSITION: (Verified 6/26/23)
None received
Prepared by: Karen Chow / SFA / (916) 651-1520
6/28/23 11:22:17
**** END ****
ASSEMBLY THIRD READING
ATR Bill Id:ACR 64
Author:(Bains)
As Introduced Ver:April 20, 2023
Majority vote
SUMMARY
Declares the month of June 2023 as Alzheimer's Disease and Brain Awareness Month, and recognizes Wednesday, June 21, 2023, as The Longest Day.
Major Provisions
- Alzheimer's disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment.
- The month of June 2023 has been declared Alzheimer's and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs.
- The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimer's disease with a day of activity and advocacy.
- California has 690,000 residents living with Alzheimer's disease, more than any other state in the nation. Recent research published by the State Department of Public Health in 2021 indicates that over the next 20 years, the impact of Alzheimer's disease and related dementia will increase dramatically. While the population of California will expand by 16%, the population of people living with Alzheimer's will expand by 127%.
- Alzheimer's disease is always fatal, and it is the third leading cause of death in California today. Alzheimer's disease is a family disease impacting 1.12 million California spouses, partners, children, siblings, grandchildren, and other relatives who provide unpaid assistance to a loved one.
- Disparities in detection and diagnosis persist, resulting in less than 50% of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record.
- On average, a person with Alzheimer's disease lives four to eight years after diagnosis, but may live as long as 20 years, depending on other factors.
- Californians invest in Alzheimer's disease research through the voluntary contribution funds and have raised more than $25 million since its inception for research into treatments to slow the progression of, and develop a cure for, the disease.
- Individuals living with Alzheimer's disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimer's disease and related dementias.
COMMENTS
According to the Author
As a practicing physician, I have seen the devastating effects of Alzheimer's on my patients and their loved ones. Highlighting past diagnostic issues within minority populations and recognizing geographic disparities will bring us closer to providing the care and understanding needed to better serve those living with Alzheimer's and those who support them.
Arguments in Support
None on file
Arguments in Opposition
None on file
FISCAL COMMENTS
No fiscal impact. This resolution is keyed non-fiscal by Legislative Counsel.
VOTES
ASM RULES: 13-0-0
YES: Ramos, Waldron, Cervantes, Juan Carrillo, Dixon, Flora, Low, Ortega, Pacheco, Papan, Pellerin, Blanca Rubio, Valencia
UPDATED
VERSION: April 20, 2023
CONSULTANT: Michael Erke / RLS. / (916) 319-2800 FN: 0001075
Date of Hearing: June 15, 2023
ASSEMBLY COMMITTEE ON RULES
James Ramos, Chair
ABPCA Bill Id:ACR 64 (
Author:Bains) – As Introduced Ver:April 20, 2023
SUBJECT: Alzheimer’s Disease and Brain Awareness Month and The Longest Day.
SUMMARY: Declares the month of June 2023 as Alzheimer’s Disease and Brain Awareness Month, and recognizes Wednesday, June 21, 2023, as The Longest Day. Specifically, this resolution makes the following legislative findings:
- Alzheimer’s disease, a progressive neurodegenerative brain disorder, tragically robs individuals of their memories and leads to cognitive decline resulting in functional, emotional, and behavioral impairment.
- The month of June 2023 has been declared Alzheimer’s and Brain Awareness Month to help educate the public on this debilitating disease and the need to increase efforts to combat its human and economic costs.
- The summer solstice, June 21, 2023, has been declared The Longest Day, with people around the world coming together to honor the strength, passion, and endurance of people facing Alzheimer’s disease with a day of activity and advocacy.
- California has 690,000 residents living with Alzheimer’s disease, more than any other state in the nation. Recent research published by the State Department of Public Health in 2021 indicates that over the next 20 years, the impact of Alzheimer’s disease and related dementia will increase dramatically. While the population of California will expand by 16 percent, the population of people living with Alzheimer’s will expand by 127 percent.
- Alzheimer’s disease is always fatal, and it is the third leading cause of death in California today. Alzheimer’s disease is a family disease impacting 1.12 million California spouses, partners, children, siblings, grandchildren, and other relatives who provide unpaid assistance to a loved one.
- Disparities in detection and diagnosis persist, resulting in less than 50 percent of individuals affected by the disease receiving a formal diagnosis that is disclosed to them by a clinician and documented in their medical record.
- On average, a person with Alzheimer’s disease lives 4 to 8 years after diagnosis, but may live as long as 20 years, depending on other factors.
- Californians invest in Alzheimer’s disease research through the voluntary contribution funds and have raised more than $25 million since its inception for research into treatments to slow the progression of, and develop a cure for, the disease.
- Individuals living with Alzheimer’s disease and their caregivers need acknowledgment, support, and services to meet their needs over the lengthy progression of Alzheimer’s disease and related dementias.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):